Deep Apple Therapeutics
Deep Apple Therapeutics is seeking a Senior Scientist to join its biology drug discovery team. The role involves designing and executing in vitro biology programs, developing assays, conducting medium- to high-throughput compound screens, and leading collaborations with CROs to advance novel targets from concept to pre‑clinical proof‑of‑principle.
Deep Apple Therapeutics is a drug discovery company leveraging deep learning and structure-based approaches — including cryo-EM structural biology, AI-powered pocket extraction, and ultra-high-volume virtual screening — to identify novel small-molecule therapeutics. Founded in 2022, the company has built a pipeline focused on inflammatory and immune diseases, as well as metabolic and endocrine disorders. Deep Apple has also announced a collaboration with Novo Nordisk to discover and develop oral therapeutics for cardiometabolic diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deep Apple Therapeutics.
Deep Apple Therapeutics didn’t post a salary, so this is our estimate from similar listings.
47% above the average for this role